Breaking News Instant updates and real-time market news.

CBT

Cabot

$48.22

2.33 (5.08%)

16:21
11/04/19
11/04
16:21
11/04/19
16:21

Cabot sees 2020 adjusted EPS $3.60-$4.10, consensus $4.30

The company said, "Looking forward to 2020, we don't yet see catalysts to improve the weak macroeconomic conditions and expect a challenging first quarter as customers aggressively manage their year-end inventory levels. Factors expected to positively impact our fiscal 2020 results include the benefits from a full year of the new China fumed silica plant and favorable outcomes of calendar year 2020 Reinforcement Materials customer agreements. We will continue to manage through the volatility in feedstock costs as a result of the new International Marine Organization (IMO) regulation that is impacting both the Reinforcement Materials and Performance Chemicals segments. We expect that Purification Solutions results will improve year-over-year as the benefits from the transformation plan continue. With the sale of the Specialty Fluids business in fiscal 2019, we will not have any EBIT contribution from this business in fiscal 2020. Thus, overall we anticipate fiscal year 2020 adjusted earnings per share to be in the range of $3.60 to $4.10. The mid-point of this range reflects a growth rate of 7% as compared to fiscal 2019 results, excluding the Specialty Fluids segment. Our long-term growth strategy and capital allocation framework will guide our actions and are underpinned by strong cash flow discipline and the strength of our investment grade balance sheet. We will continue to invest in attractive growth projects across our core segments and we remain committed to returning cash to our shareholders."

  • 05

    Nov

CBT Cabot
$48.22

2.33 (5.08%)

08/05/19
08/05/19
DOWNGRADE
Target $41

Hold
Cabot downgraded to Hold from Buy at Loop Capital
As previously reported, Loop Capital analyst Chris Kapsch downgraded Cabot (CBT) to Hold and lowered his price target to $41 from $69 ahead of its Q3 results today. The analyst no longer sees "enough constructive fundamental dynamics" to warrant a bullish stance on the stock, stating that the challenges for the carbon black industry implied in the rival Orion Engineered Carbon's (OEC) commentary last week suggests that Cabot may also indicate "incrementally challenging industry conditions."
10/10/19
UBSW
10/10/19
INITIATION
Target $45
UBSW
Neutral
Cabot initiated with a Neutral rating at UBS
UBS analyst Joshua Spector initiated coverage of Cabot with a Neutral rating and $45 price target. The analyst sees a balanced risk/reward with higher than average near term earnings risks. The company has been under pressure as volumes were impacted by destocking in the plastics chain, lower production in autos, and changing feedstock dynamics, says the analyst.
10/16/19
BARD
10/16/19
DOWNGRADE
Target $45
BARD
Neutral
Cabot downgraded to Neutral from Outperform at Baird
Baird analyst Ben Kallo downgraded Cabot to Neutral from Outperform with a $45 price target.
10/16/19
BARD
10/16/19
DOWNGRADE
Target $45
BARD
Neutral
Cabot downgraded to Neutral at Baird
As reported previously, Baird analyst Ben Kallo downgraded Cabot to Neutral from Outperform. The analyst cited a challenging macro backdrop including softness in China and slower global auto production. He believes it will be an overhang on Cabot for several quarters. Kallo maintained his $45 price target on Cabot shares.

TODAY'S FREE FLY STORIES

MAS

Masco

$46.01

0.445 (0.98%)

17:35
12/05/19
12/05
17:35
12/05/19
17:35
Hot Stocks
Masco CFO sells 20K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CI

Cigna

$195.52

-1.13 (-0.57%)

17:31
12/05/19
12/05
17:31
12/05/19
17:31
Hot Stocks
Cigna's Foss acquires over 10,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 06

    Feb

GD

General Dynamics

$182.38

4.26 (2.39%)

17:30
12/05/19
12/05
17:30
12/05/19
17:30
Hot Stocks
General Dynamics awarded $145.75M Navy contract modification »

General Dynamics was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOCU

DocuSign

$69.51

-0.465 (-0.66%)

17:28
12/05/19
12/05
17:28
12/05/19
17:28
Hot Stocks
DocuSign up 8.5% to $75.38 after Q3 results beat estimates »

The company also raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 09

    Dec

  • 16

    Dec

DASTY

Dassault Systemes

$0.00

(0.00%)

17:24
12/05/19
12/05
17:24
12/05/19
17:24
Initiation
Dassault Systemes initiated  »

Dassault Systemes resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ULTA

Ulta Beauty

$236.09

-3.27 (-1.37%)

17:24
12/05/19
12/05
17:24
12/05/19
17:24
Hot Stocks
Ulta Beauty up 10% to $259.20 after Q3 profit beat estimates »

The company also narrowed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

AUMN

Golden Minerals

$0.30

0.0089 (3.07%)

17:21
12/05/19
12/05
17:21
12/05/19
17:21
Syndicate
Breaking Syndicate news story on Golden Minerals »

Golden Minerals files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YEXT

Yext

$16.62

0.065 (0.39%)

17:18
12/05/19
12/05
17:18
12/05/19
17:18
Hot Stocks
Breaking Hot Stocks news story on Yext »

Yext down 21% to $13.00…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

FIZZ

National Beverage

$48.28

-1.16 (-2.35%)

17:16
12/05/19
12/05
17:16
12/05/19
17:16
Earnings
National Beverage reports Q2 EPS 70c, consensus 68c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXSM

Axsome Therapeutics

$43.27

-4.17 (-8.79%)

17:16
12/05/19
12/05
17:16
12/05/19
17:16
Syndicate
Breaking Syndicate news story on Axsome Therapeutics »

Axsome Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTHT

Huazhu Group

$34.49

1.58 (4.80%)

17:15
12/05/19
12/05
17:15
12/05/19
17:15
Upgrade
Huazhu Group rating change  »

Huazhu Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONDS

Ondas Holdings

$0.00

(0.00%)

17:12
12/05/19
12/05
17:12
12/05/19
17:12
Syndicate
Breaking Syndicate news story on Ondas Holdings »

Ondas Holdings files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GH

Guardant Health

$73.57

-1.43 (-1.91%)

17:11
12/05/19
12/05
17:11
12/05/19
17:11
Hot Stocks
Guardant Health Chief Medical Officer Richard Lanman to retire »

On December 2, Richard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DEI

Douglas Emmett

$44.13

0.1 (0.23%)

17:10
12/05/19
12/05
17:10
12/05/19
17:10
Hot Stocks
Douglas Emmett raises quarterly dividend by 8% to 28c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXSM

Axsome Therapeutics

$43.27

-4.17 (-8.79%)

17:06
12/05/19
12/05
17:06
12/05/19
17:06
Syndicate
Breaking Syndicate news story on Axsome Therapeutics »

Axsome Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZM

Zoom Video

$69.73

-0.22 (-0.31%)

17:06
12/05/19
12/05
17:06
12/05/19
17:06
Periodicals
Zoom Video shares fall on moderating revenue growth, CNBC reports »

Zoom's revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 16

    Dec

TRIP

TripAdvisor

$29.04

0.51 (1.79%)

, EIGI

Endurance

$4.04

-0.06 (-1.46%)

17:03
12/05/19
12/05
17:03
12/05/19
17:03
Hot Stocks
TripAdvisor acquires SinglePlatform from Endurance, terms not disclosed »

TripAdvisor (TRIP)…

TRIP

TripAdvisor

$29.04

0.51 (1.79%)

EIGI

Endurance

$4.04

-0.06 (-1.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BP

BP

$36.63

-0.45 (-1.21%)

, COP

ConocoPhillips

$59.83

-0.8 (-1.32%)

16:56
12/05/19
12/05
16:56
12/05/19
16:56
Periodicals
OPEC cancels customary press conference after meeting, CNBC reports »

Amid reports that OPEC…

BP

BP

$36.63

-0.45 (-1.21%)

COP

ConocoPhillips

$59.83

-0.8 (-1.32%)

TOT

Total

$52.29

0.02 (0.04%)

XOM

Exxon Mobil

$68.41

-0.24 (-0.35%)

CVX

Chevron

$116.30

-0.66 (-0.56%)

RDS.A

Royal Dutch Shell

$56.50

-0.34 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$60.11

-89.11 (-59.72%)

16:53
12/05/19
12/05
16:53
12/05/19
16:53
Recommendations
Sage Therapeutics analyst commentary  »

Sage Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMN

Eastman Chemical

$75.68

0.67 (0.89%)

16:43
12/05/19
12/05
16:43
12/05/19
16:43
Hot Stocks
Eastman Chemical raises quarterly dividend 6.5% to 66c from 62c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVRI

Everi Holdings

$11.86

-1 (-7.78%)

16:43
12/05/19
12/05
16:43
12/05/19
16:43
Syndicate
Everi Holdings 10M share Secondary priced at $11.25 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

ZUMZ

Zumiez

$30.63

0.67 (2.24%)

16:39
12/05/19
12/05
16:39
12/05/19
16:39
Earnings
Zumiez raises FY19 SSS growth view to 4.0%-4.5% from prior view 2.0%-4.0% »

Based upon better than…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

16:38
12/05/19
12/05
16:38
12/05/19
16:38
Earnings
Crowdstrike raises FY20 EPS view to (53c)-(52c) from (65c)-(62c) »

Consensus (63c). Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

FNHC

Federated National

$15.37

-0.04 (-0.26%)

16:36
12/05/19
12/05
16:36
12/05/19
16:36
Hot Stocks
Federated National announces new $10M share repurchase program »

Federated National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

16:36
12/05/19
12/05
16:36
12/05/19
16:36
Earnings
Crowdstrike sees Q4 adjusted EPS (9c)-(8c), consensus (11c) »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.